Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Personal Author:
Haber, Penina ; Schembri, Christopher P. ; Lewis, Paige ; Hibbs, Beth ; Shimabukuro, Tom T. ;
Haber, Penina ; Schembri, Christopher P. ; Lewis, Paige ; Hibbs, Beth ; Shimabukuro, Tom T. ; Less -
Description:
Annual influenza vaccination is recommended for all persons aged ≥6 months. Two vaccine types are approved in the United States, injectable inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV), which is administered intranasally. Influenza vaccine typicaly becomes widely available beginning in late summer or early fall. IIV has a standard expiration date of June 30 for any given influenza season (July 1 through June 30 of the following year). In contrast, after release for distribution, LAIV generally has an 18-week shelf life (Christopher Ambrose, MedImmune, personal communication, 2014). Because of its relatively short shelf life, LAIV might be more likely than IIV to be administered after its expiration date. To assess that hypothesis, CDC analyzed reports to the Vaccine Adverse Event Reporting System (VAERS) of expired LAIV administered during July 1, 2007, through June 30, 2014.
Subject:
[+]
Drug Storage
Humans
Influenza, Human
Influenza Vaccines
Notes From The Field
Vaccines, Attenuated

Source:
MMWR Morb Mortal Wkly Rep. 2014 ; 63(35):773.;
Pubmed ID:
25188496
Pubmed Central ID:
PMC5779452
Document Type:
Journal Article ;
Place as Subject:
United States ;
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:53a33da117632899a30a25b0cfbb7fd43e9890cb708df953df6828523ea61331
File Type:

Supporting Files

• 773.nxml

  xml

More +